Skip to main content

Table 1 Demographic and baseline characteristics of patients with septic shock

From: Selepressin, a novel selective vasopressin V1A agonist, is an effective substitute for norepinephrine in a phase IIa randomized, placebo-controlled trial in septic shock patients

 

Selepressin 1.25 ng/kg/minute (n = 10)

Selepressin 2.5 ng/kg/minute (n = 19)

Selepressin 3.75 ng/kg/minute (n = 2)

Placebo (n = 21)

Demographics

 Sex

  Female/male, n (%)

7 (70%)/3 (30%)

9 (47%)/10 (53%)

1 (50%)/1 (50%)

6 (29%)/15 (71%)

 Age, years, mean (SD; median)

59.3 (19.6–62.5)

57.1 (15.4–59)

69 (12.7–69)

63.2 (18–66)

 Weight, kg, mean (SD; median)

64.8 (14.3–63)

87.6 (28.6–85)

77.5 (17.7–78)

75.1 (15.3–75)

 Total SOFA score, mean (SD; median)

9.3 (2.2–9.5)

11.2 (3.7–11)

12 (0: 12)

10.4 (3.5–11)

 Lactate, mEq/L, mean (SD)

2.5 (1.5)

3.0 (2.9)

7.5 (8.1)

2.5 (1.4)

 Mean arterial pressure, mmHg, mean (SD; median)

66 (13–63)

74 (9–70)

69 (15–69)

74 (13–69)

 Heart rate, beats/minute, mean (SD; median)

90 (17–94)

97 (20–91)

110 (6–110)

90 (20–93)

 Norepinephrine, μg/kg/minute, mean (SD)

0.18 (0.09)

0.28 (0.26)

0.39 (0.20)

0.34 (0.35)

 PaO2/FiO2, mean (SD; median)

231 (108–200)

257 (133–233)

221 (24–221)

246 (129–198)

Primary infection type

 Bacterial, n (%)

7 (70%)

14 (74%)

2 (100%)

15 (71%)

 Unknown, n (%)

3 (30%)

5 (26%)

 

5 (24%)

 Other, n (%)

   

1 (5%)

Primary infection location

 Urinary tract, n (%)

1 (10%)

2 (11%)

 

1 (5%)

 Lung, n (%)

1 (10%)

6 (32%)

1 (50%)

8 (38%)

 Abdomen, n (%)

4 (40%)

8 (42%)

 

9 (43%)

 Unknown, n (%)

2 (20%)

  

1 (5%)

 Other, n (%)

2 (20%)

3 (16%)

1 (50%)

2 (10%)

Main concomitant diseases

 Gastrointestinal, n (%)

8 (80%)

14 (74%)

1 (50%)

20 (95%)

 Metabolic, n (%)

6 60%)

16 (84%)

2 100%)

18 (86%)

 Respiratory, n (%)

7 (70%)

12 (63%)

2 100%)

14 (67%)

 Renal, n (%)

5 (50%)

11 (58%)

1 (50%)

16 (76%)

Subjects on mechanical ventilation

4 (40%)

11 (58%)

0

15 (71%)

  1. PaO 2 /FiO 2 Ratio of partial pressure arterial oxygen and fraction of inspired oxygen, SOFA Sequential Organ Failure Assessment